{"filing":{"accession_number":"0001193125-26-347825","cik":"0001930313","ticker":"SBCWW","company_name":"SBC Medical Group Holdings Inc","form":"8-K","filing_date":"2026-08-13","report_date":"2026-08-13","primary_document":"sbc-20260813.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1930313/000119312526347825/sbc-20260813.htm"},"events":[{"id":27441,"run_id":25015,"accession_number":"0001193125-26-347825","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.97,"summary":"SBC Medical Group Holdings issued a press release on August 13, 2026 announcing consolidated financial results for the second quarter ended June 30, 2026, including quarterly revenue of $49 million (up 13% YoY), net income of $11 million (up 335% YoY), and adjusted EBITDA of $20 million (up 32% YoY), along with detailed financial tables and management commentary.","company_name":"SBC Medical Group Holdings Inc","ticker":"SBCWW","filing_date":"2026-08-13","form":"8-K","submitted_at":null,"items":[{"id":28986,"accession_number":"0001193125-26-347825","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"SBC Medical Group Holdings issued a press release on August 13, 2026 announcing its consolidated financial results for the second quarter ended June 30, 2026. The disclosure includes quarterly revenue of $49 million (up 13% YoY), net income of $11 million (up 335% YoY), and adjusted EBITDA of $20 million (up 32% YoY), along with detailed financial tables and management commentary. This is a standard earnings release filed under Item 2.02 and attached as Exhibit 99.1, which is material to investors assessing the registrant's financial performance and growth trajectory.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-13T10:51:41.481012+00:00","company_name":"","ticker":null,"filing_date":""},{"id":28987,"accession_number":"0001193125-26-347825","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The Item 7.01 disclosure announces SBC Medical's second quarter 2026 financial results via investor presentations posted to the company's website on August 13, 2026. The supplemental exhibit (EX-99.1) contains a full earnings release showing Q2 2026 revenue of $49 million (up 13% YoY), net income of $11 million (up 335% YoY), and adjusted EBITDA of $20 million (up 32% YoY), along with detailed financial statements and management commentary. This is a material earnings disclosure that would affect a reasonable investor's assessment of the company's financial performance and prospects.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-13T10:51:41.481012+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":28986,"accession_number":"0001193125-26-347825","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"SBC Medical Group Holdings issued a press release on August 13, 2026 announcing its consolidated financial results for the second quarter ended June 30, 2026. The disclosure includes quarterly revenue of $49 million (up 13% YoY), net income of $11 million (up 335% YoY), and adjusted EBITDA of $20 million (up 32% YoY), along with detailed financial tables and management commentary. This is a standard earnings release filed under Item 2.02 and attached as Exhibit 99.1, which is material to investors assessing the registrant's financial performance and growth trajectory.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-13T10:51:41.481012+00:00","company_name":"SBC Medical Group Holdings Inc","ticker":"SBCWW","filing_date":"2026-08-13"},{"id":28987,"accession_number":"0001193125-26-347825","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The Item 7.01 disclosure announces SBC Medical's second quarter 2026 financial results via investor presentations posted to the company's website on August 13, 2026. The supplemental exhibit (EX-99.1) contains a full earnings release showing Q2 2026 revenue of $49 million (up 13% YoY), net income of $11 million (up 335% YoY), and adjusted EBITDA of $20 million (up 32% YoY), along with detailed financial statements and management commentary. This is a material earnings disclosure that would affect a reasonable investor's assessment of the company's financial performance and prospects.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-13T10:51:41.481012+00:00","company_name":"SBC Medical Group Holdings Inc","ticker":"SBCWW","filing_date":"2026-08-13"}]}